| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▲ | 1.49▲ | 1.50▲ | 1.50▲ | 1.43▲ |
| MA10 | 1.50▲ | 1.49▲ | 1.49▲ | 1.47▲ | 1.46▲ |
| MA20 | 1.49▲ | 1.46▲ | 1.46▲ | 1.45▲ | 1.44▲ |
| MA50 | 1.46▲ | 1.44▲ | 1.44▲ | 1.47▲ | 2.33▼ |
| MA100 | 1.45▲ | 1.47▲ | 1.48▲ | 1.44▲ | 11.23▼ |
| MA200 | 1.48▲ | 1.45▲ | 1.44▲ | 1.89▼ | 141.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.004▲ | 0.006▲ | 0.010▲ | 0.149▲ |
| RSI | 57.314▲ | 57.129▲ | 56.521▲ | 56.036▲ | 41.224▼ |
| STOCH | 44.444 | 48.291 | 72.852 | 54.658 | 47.398 |
| WILL %R | -33.333 | -19.048▲ | -14.815▲ | -29.031 | -28.041 |
| CCI | 37.949 | 89.110 | 91.017 | 151.405▲ | 47.035 |
|
Friday, November 13, 2026 01:05 PM
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 1.52 | 1.5721 | 1.51 | 1.515 | 17,583 |
| 12/11/26 | 1.53 | 1.5399 | 1.47 | 1.52 | 32,246 |
| 11/11/26 | 1.3807 | 1.579 | 1.3807 | 1.49 | 10,665 |
| 10/11/26 | 1.47 | 1.53 | 1.455 | 1.51 | 38,237 |
| 09/11/26 | 1.41 | 1.47 | 1.41 | 1.44 | 19,035 |
| 06/11/26 | 1.3901 | 1.46 | 1.3803 | 1.424 | 10,610 |
| 05/11/26 | 1.46 | 1.46 | 1.37 | 1.40 | 40,328 |
| 04/11/26 | 1.58 | 1.58 | 1.43 | 1.46 | 35,800 |
| 03/11/26 | 1.45 | 1.51 | 1.41 | 1.50 | 43,270 |
| 02/11/26 | 1.41 | 1.54 | 1.41 | 1.45 | 28,403 |
|
|
||||
|
|
||||
|
|